Jyothy Laboratories Ltd NSE  /  BSE

FMCG, Mid Cap

16 Jul 2019 | 04:14 PM

162.15
0.50 (0.31%)

Independent Research

theScreeners

We bring you Independent research views from famous names like Reuters and theScreeners to help improve your investing results and create wealth

Star Rating

Initiated on 01-01-70

Target Price

Performance parameters

  • Earnings Revision Trend

    Analysts neutral but previously negative (since 29-Jan-2019)

    Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 29-Jan-2019 at a price of 179.70.

  • Valuation Rating

    Fairly priced

    Based on its growth potential and our own criteria, at its current price the stock is fairly valued.

  • MT Tech Trend

    Trend neutral but previously positive (since 12-Mar-2019)

    The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 12-Mar-2019), the stock traded above its moving average. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 183.334.

  • 4W REL Performance

    Under pressure (vs. SENSEX30)

    The four week relative underperformance versus SENSEX30 is -2.840.

Risk parameters

  • Risk Zone

    Low

    The stock has been on the low-sensitivity level since 18-May-2018.

  • Bear Market

    Below average sensitivity to market corrections

    On average, the stock has a tendency to minimize the drops in the index by -68%.

  • Bad News

    Slight market sanction in case of specific pressure

    When the stock's pressure is specific, the market sanction on average is 236%.

  • Beta

    22 Low sensitivity to SENSEX30

    For 1% of index variation, the stock varies on average by 22%.

  • Correlation

    0.08 Weak correlation to SENSEX30

    Stock movements are totally independent of index variations.

  • Value at Risk

    Rs.19.53 The medium term value at risk is estimated at 19.53 or 0.10558%

    The value at risk is estimated at 19.53. The risk is therefore 0.10558%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.

Other parameters

  • LT Growth

    21.61 Current year to 2021 annualized estimate

    The annualized growth estimate is for the current year to 2021.

  • P/E Ratio

    25.73 Estimated PE for 2021

    The estimated PE is for the year 2021.

  • G/PE Ratio

    0.9 0.163% premium to expected growth

    A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: 0.163% premium.

  • Dividend Yield

    1.51% Dividend is largely covered by profits

    The twelve month estimated dividend yield represents 38.767% of earnings forecasts.

  • Global Evaluation

    Slightly positive

    The stock is classified in the slightly positive zone since 01-Feb-2019.